Lépine J-P, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat 2011; 7: 3–7.
 Wittchen H-U, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–376.
 Freeman A, Tyrovolas S, Koyanagi A, et al. The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe). BMC Public Health 2016; 16: 1098.
 Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998; 158: 1422–6.
 Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278–85.
 Ohira T, Iso H, Satoh S, et al. Prospective study of depressive symptoms and risk of stroke among japanese. Stroke 2001; 32: 903–8.
 Salinero-Fort MA, Gómez-Campelo P, San Andrés-Rebollo FJ, et al. Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study) : results from the MADIABETES cohort. BMJ Open 2018; 8: e020768.
 Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069–78.
 Fisher L, Skaff MM, Mullan JT, et al. Clinical Depression Versus Distress Among Patients With Type 2 Diabetes: Not just a question of semantics. Diabetes Care 2007; 30: 542–548.
 Mantyselka P, Korniloff K, Saaristo T, et al. Association of Depressive Symptoms With Impaired Glucose Regulation, Screen-Detected, and Previously Known Type 2 Diabetes: Findings from the Finnish D2D Survey. Diabetes Care 2011; 34: 71–76.
 Cuschieri S, Vassallo J, Calleja N, et al. The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study. Arch Public Heal; 74. Epub ahead of print 2016. DOI: 10.1186/s13690-016-0164-6.
 Cuschieri S, Mamo J. Malta: Mediterranean diabetes hub – A journey through the years. Malta Med J; 26.
 Cuschieri S, Vassallo J, Calleja N, et al. Diabetes, pre-diabetes and their risk factors in Malta: A study profile of national cross-sectional prevalence study. Glob Heal Epidemiol Genomics; 1. Epub ahead of print 2016. DOI: 10.1017/gheg.2016.18.
 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–13.
 Katon W, von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004; 27: 914–20.
 Mitchell AJ, Yadegarfar M, Gill J, et al. Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies. Br J Psychiatry Open 2016; 2: 127–138.
 American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care 2016; 39 Suppl 1: S13-22.
 World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Heal Organ 2013; 102.
 Mommersteeg PMC, Herr R, Pouwer F, et al. The association between diabetes and an episode of depressive symptoms in the 2002 World Health Survey: an analysis of 231 797 individuals from 47 countries. Diabet Med 2013; 30: e208–e214.
 Egede LE, Ellis C. Diabetes and depression: Global perspectives. Diabetes Res Clin Pract 2010; 87: 302–312.
 Nouwen A, Nefs G, Caramlau I, et al. Prevalence of Depression in Individuals With Impaired Glucose Metabolism or Undiagnosed Diabetes: A systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011; 34: 752–762.
 Gentil L. Depression and Diabetes: A Major Public Health Problem. Ann Depress Anxiety 2015; 2: 1052.
 Hamer M, Batty GD, Stamatakis E, et al. Hypertension awareness and psychological distress. Hypertens (Dallas, Tex 1979) 2010; 56: 547–50.
 Alzoubi A, Abunaser R, Khassawneh A, et al. The Bidirectional Relationship between Diabetes and Depression: A Literature Review. Korean J Fam Med 2018; 39: 137–146.
 Eldor R, Raz I. American Diabetes Association indications for statins in diabetes: is there evidence? Diabetes Care 2009; 32 Suppl 2: S384-91.
 Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007; 62: 31–38.
 Ismail K, Moulton CD, Winkley K, et al. The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study. Diabetologia 2017; 60: 2092–2102.
 Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23: 934–42.
 Lin EHB, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154–60.
 Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and Diabetes Treatment Nonadherence: A Meta-Analysis. Diabetes Care 2008; 31: 2398–2403.
 Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2. Med Care 2003; 41: 1284–1292.
 Beck Depression Inventory. Occup Med (Chic Ill) 2016; 66: 174–175.
 Kroenke K, Spitzer RL, Williams JBW, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010; 32: 345–359.